This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors | MicrobiomeTrials
← Back to trials NCT06535607
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors Recruiting PHASE2 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2024-08-22Est. Completion: 2028-11-30
Enrollment target: 257 participantsLocations Research Site, Los Angeles, California, United States Research Site, Baltimore, Maryland, United States Research Site, New York, New York, United States Research Site, Stony Brook, New York, United States Research Site, Columbus, Ohio, United States Research Site, Columbus, Ohio, United States Research Site, Philadelphia, Pennsylvania, United States Research Site, Clayton, Australia Research Site, Nedlands, Australia Research Site, Ijuí, Brazil Research Site, Londrina, Brazil Research Site, Natal, Brazil Research Site, Porto Alegre, Brazil Research Site, Santo André, Brazil Research Site, São Caetano do Sul, Brazil Research Site, Vitória, Brazil Research Site, Vitória, Brazil Research Site, Edmonton, Alberta, Canada Research Site, Montreal, Quebec, Canada Research Site, Anyang, China
Research Site, Beijing, China
Research Site, Beijing, China
Research Site, Beijing, China
Research Site, Beijing, China
Research Site, Beijing, China
Research Site, Bengbu, China
Research Site, Changchun, China
Research Site, Changchun, China
Research Site, Changsha, China
Research Site, Changsha, China
Research Site, Changsha, China
Research Site, Changsha, China
Research Site, Chengdu, China
Research Site, Chengdu, China
Research Site, Chengdu, China
Research Site, Chongqing, China
Research Site, Chongqing, China
Research Site, Dongguan, China
Research Site, Dongguan, China
Research Site, Fuzhou, China
Research Site, Fuzhou, China
Research Site, Fuzhou, China
Research Site, Guangzhou, China
Research Site, Hangzhou, China
Research Site, Harbin, China
Research Site, Hefei, China
Research Site, Jining, China
Research Site, Kunming, China
Research Site, Kunming, China
Research Site, Nanchang, China
Research Site, Nanjing, China
Research Site, Nanning, China
Research Site, Nanning, China
Research Site, Shandong, China
Research Site, Shandong, China
Research Site, Shandong, China
Research Site, Shandong, China
Research Site, Shanghai, China
Research Site, Shenyang, China
Research Site, Tianjin, China
Research Site, Tianjin, China
Research Site, Wuhan, China
Research Site, Wuhan, China
Research Site, Wuhan, China
Research Site, Wuhan, China
Research Site, Wuhan, China
Research Site, Wuhou District, China
Research Site, Zhengzhou, China
Research Site, Cologne, Germany
Research Site, Frankfurt, Germany
Research Site, Gauting, Germany
Research Site, Großhansdorf, Germany
Research Site, Hamburg, Germany
Research Site, Heidelberg, Germany
Research Site, Mainz, Germany
Research Site, Münster, Germany
Research Site, Offenbach, Germany
Research Site, Regensburg, Germany
Research Site, Alessandria, Italy
Research Site, Bergamo, Italy
Research Site, Orbassano, Italy
Research Site, Kashiwa, Japan
Research Site, Yokohama, Japan
Research Site, Incheon, South Korea
Research Site, Namdong-gu, South Korea
Research Site, Seoul, South Korea
Research Site, Seoul, South Korea
Research Site, Kaohsiung City, Taiwan
Research Site, Kaohsiung City, Taiwan
Research Site, Kaohsiung City, Taiwan
Research Site, Taichung, Taiwan
Research Site, Taipei, Taiwan
Research Site, Taipei, Taiwan
Research Site, Cambridge, United Kingdom
Research Site, Glasgow, United Kingdom
Research Site, Manchester, United Kingdom
Research Site, Hanoi, Vietnam
Research Site, Ho Chi Minh City, Vietnam